Baby Carrier Intervention for Maternal Mental Health
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether using a baby carrier can improve the bond between mothers and their babies, particularly for mothers experiencing anxiety or depression. Researchers aim to determine if this method facilitates connection with their babies and enhances overall well-being. Participants will either use a baby carrier or join a waitlist, with mothers sharing their experiences and answering questions about their mood and relationship with their baby. This trial suits mothers in the Montreal area who have recently given birth to a healthy baby and are dealing with anxiety or depression. As an unphased trial, it offers a unique opportunity for mothers to contribute to understanding new ways to support maternal mental health and bonding.
Do I need to stop my current medications for the trial?
The trial does not specify if you need to stop your current medications, but you cannot participate if you are taking medications that make you feel drowsy or dizzy.
What prior data suggests that this baby carrier intervention is safe for mothers and infants?
Research shows that using a baby carrier is generally safe for both mothers and babies. One study found that an ergonomic baby carrier can help reduce symptoms of postpartum depression in mothers. Regular and safe use of a baby carrier might offer mental health benefits.
Other studies on babywearing suggest it can improve bonding between mother and child, enhancing emotional health for both. These studies have not reported any major safety concerns. The baby carriers are designed to be ergonomic, providing comfort and support for both the wearer and the baby.
Overall, using baby carriers is considered safe and has not been linked to any major negative effects. This makes it a good option for mothers seeking to strengthen their connection with their babies.12345Why are researchers excited about this trial?
Researchers are excited about the Baby Carrier Intervention for maternal mental health because it offers a unique approach by fostering physical closeness and bonding between mothers and their infants through babywearing. Unlike traditional treatments for maternal mental health, which might involve medication or therapy, this intervention focuses on enhancing mother-infant interaction and emotional connection. The intervention's emphasis on using ergonomic baby carriers to promote bonding could potentially improve maternal sensitivity and reduce symptoms of depression and anxiety, offering a non-invasive, supportive method to enhance mental well-being postpartum.
What evidence suggests that the baby carrier intervention is effective for improving maternal mental health?
This trial will evaluate the impact of the Baby Carrier Intervention on maternal mental health. Studies have shown that baby carriers can significantly reduce depression in new mothers. Research also suggests that baby carriers can strengthen the bond between mothers and their babies, which is crucial for the baby's development. Since a mother's stress and bonding with her baby are connected, reducing stress through a baby carrier might enhance their bond. By keeping the baby close, baby carriers can help mothers feel more attuned and connected with their babies. Overall, these methods show promise in supporting mothers' mental health and improving their relationship with their babies.15678
Are You a Good Fit for This Trial?
This trial is for mothers who are feeling anxious or depressed during pregnancy. They should be willing to use a baby carrier regularly and participate in home visits and interviews. Mothers with allergies that could be triggered by the baby carrier material, or other conditions that might interfere with the study, cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants in the intervention group use a soft ergonomic baby carrier for a prescribed amount of time over a period of six weeks. Weekly adherence self-reports are collected.
Follow-up
Participants are monitored for feasibility, acceptability, and clinical utility of the intervention, including maternal sensitivity and inter-personal neural synchrony.
What Are the Treatments Tested in This Trial?
Interventions
- Baby Carrier Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sir Mortimer B. Davis - Jewish General Hospital
Lead Sponsor
Brain Canada
Collaborator